Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in VCEL — Vericel Corp

CIK 1000275 TORONTO, A6
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$34,513,647
+$6,134,498 QoQ
Shares Held
775,762
-12.1% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 24% Shared 20% None 57%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. VCEL ranks #11 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in VCEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,513,647 775,762
2026-03-31 $28,379,149 882,162
2025-12-31 $35,831,891 995,054
2025-09-30 $31,989,189 1,016,498
2025-06-30 $44,740,429 1,051,479
2025-03-31 $42,410,681 950,486
2024-12-31 $49,147,192 895,050
2024-09-30 $37,938,554 897,954
2024-06-30 $34,958,355 761,952
2024-03-31 $30,146,002 579,508
2023-12-31 $7,018,015 197,080
2023-09-30 $6,380,630 190,353
2023-06-30 $7,004,472 186,438
2023-03-31 $5,275,310 179,922
2022-12-31 $4,417,109 167,696
2022-09-30 $4,219,289 181,866
2022-06-30 $4,575,658 181,718
2022-03-31 $7,446,171 194,824
2021-12-31 $4,901,966 124,732
2021-09-30 $5,876,787 120,426
2021-06-30 $5,072,286 96,615
2021-03-31 $1,993,854 35,893
2020-12-31 $81,090 2,626
2020-09-30 $34,021 1,836
2020-06-30 $28,883 2,090
2020-03-31 $11,233 1,225